Alyssa Craig serves as the Genetics Supervisor and Data Specialist at Oncosure Testing, where she leads laboratory operations supporting advanced genetic and oncology testing. She oversees the full testing lifecycle, including sample processing, assay execution, quality control, and bioinformatics workflows, ensuring accuracy, efficiency, and the highest standards of data integrity.

In her role, Alyssa drives assay development and validation initiatives, maintains robust quality systems, and ensures compliance with CLIA, HIPAA, OSHA, and applicable state regulations. She is instrumental in maintaining inspection readiness, implementing continuous process improvements, and supporting scalable laboratory growth.

With a strong background in molecular diagnostics, Alyssa brings extensive experience across next-generation sequencing (NGS), pharmacogenomics, qRT-PCR, and clinical chemistry. She has successfully led high-complexity laboratory teams, implemented new testing platforms, and supported laboratories through validation and regulatory consulting.

Alyssa is triple board certified through the American Association of Bioanalysts (AAB), American Society for Clinical Pathology (ASCP), and American Medical Technologists (AMT), and holds a Clinical Laboratory Supervisor license in Molecular Pathology. She earned her Bachelor of Science in Forensic Chemistry and is currently pursuing her PhD in Biochemistry and Molecular Biology at the University of Miami. Alyssa is dedicated to advancing precision medicine through high-quality genetic testing and innovative laboratory practices.

William Wysock is a seasoned molecular scientist with over two decades of experience in clinical and translational research, specializing in molecular diagnostics and infectious disease biology. He holds a Bachelor of Arts in Writing from Loyola University of Maryland and a Master of Science in Biology from the Catholic University of America. His unique interdisciplinary background combines scientific rigor with clear, analytical communication, a valuable asset in both research and laboratory operations.

Mr. Wysock is certified in Molecular Biology by the American Society for Clinical Pathology and has extensive expertise in advanced molecular methodologies, including polymerase chain reaction (PCR) techniques, next-generation sequencing (NGS), and the implementation of laboratory quality systems. He is also trained in Six Sigma methodologies and holds a Green Belt certification, underscoring his commitment to operational efficiency and process improvement.

In his role as Molecular Scientist, Mr. Wysock is principally responsible for overseeing the laboratory's validation processes. This includes designing and executing method verification studies, analyzing performance metrics, and ensuring all assays meet stringent analytical and clinical standards prior to implementation. His in-depth knowledge of assay development and regulatory requirements plays a critical role in maintaining the scientific credibility and compliance integrity of the laboratory.

Mr. Wysock also serves as the laboratory’s primary resource for complex technical inquiries. He provides expert guidance on molecular workflows, troubleshooting protocols, and optimizing assay performance, thereby supporting both day-to-day operations and long-term innovation. His leadership in this capacity ensures that laboratory personnel are equipped with the technical insights necessary for high-complexity testing.

A prolific contributor to the scientific literature, Mr. Wysock has authored numerous peer-reviewed publications in the fields of molecular diagnostics and infectious disease research. His scholarly work reflects a sustained commitment to advancing laboratory science and integrating evidence-based practices into clinical diagnostics. Through his analytical acumen, mentorship, and research-driven approach, William Wysock significantly enhances the laboratory's capacity for precision medicine and scientific advancement.